Valkyrie BioSciences
Lindon, Utah ("Silicon Slopes")
Investment Overview
Current Valuation
$2,500,000.00
Raising Amount
$1,950,000.00
Stage
Seed
Minimum Investment
$2,050,000.00
Valkyrie BioScience is a healthcare technology company headquartered in Lindon, Utah, focused on transforming dental diagnostics through advanced imaging, AI, and cloud‑based tools. Its flagship FDA‑cleared product, Lumos 3DX™, is a mobile, cloud‑based 3D dental imaging system powered by proprietary Lumos Vue software, providing real‑time analysis of caries, cracked teeth, early‑stage bone loss, and pulp/enamel conditions. The company also offers the FinScan 350, a 3‑in‑1 CBCT, panoramic, and cephalometric imaging platform. Founded in 2019 (as 3Dio, Inc.) by Dr. Douglas Hansen and now led by CEO & Chairman Michael Stevens, Valkyrie operates a state‑of‑the‑art R&D, development, and fulfillment facility in Lindon, Utah, with a mission to equip dental professionals with diagnostic technology that enhances precision and improves patient care.
Company Highlights
Product Sales
The Problem
Product development & R&D 35% (next‑generation tomosynthesis imaging, including the veterinary product portfolio), sales & marketing expansion 30% (national sales infrastructure and clinical education), manufacturing & fulfillment scale‑up 20% (Lindon, UT facility), operations & working capital 15%.
Team
CEO & Chairman: Michael Stevens – Healthcare growth executive, 25+ yrs commercial strategy; founder of Apex Dental Materials | COO & Co-Founder: Douglas Hansen, Ph.D – Ph.D. Physics (BYU), 30+ yrs high-tech product leadership | VP Sales: Matt Hunt – 35+ yrs dental/medical device sales (BIOLASE, Henry Schein) | VP Regulatory & QMS: Alicia Mszyca – Regulatory/quality exec (KaVo Kerr, BIOLASE) | Butch Dorian – 10+ yrs CFO experience, MBA Columbia/Berkeley | Brad Allen – 16 yrs medical device development & manufacturing | Josh Cates – 25 yrs medical image processing / machine learning | Richard P. Anderson, DDS – 30 yrs clinical dentistry, digital dentistry mentor
Michael Stevens
Chief Executive Officer & Chairman
Growth-focused healthcare executive with 25+ years of experience in commercial strategy, marketing, and bringing disruptive technologies to market. Founder of Apex Dental Materials, which he grew into a premier industry player over 14 years. Expertise spans go-to-market development, capital strategy, M&A, and strategic partnerships in the dental and biotech sectors.
Welcome to
Valkyrie BioSciences
Healthcare technology company transforming dental diagnostics through AI‑powered, cloud‑based 3D tomosynthesis imaging — starting with the FDA‑cleared Lumos 3DX chairside system and FinScan 350 CBCT platform.